Home
Scholarly Works
EGFR Tyrosine Kinase Inhibitors and Combination...
Conference

EGFR Tyrosine Kinase Inhibitors and Combination Strategies in First-line Treatment of Advanced NSCLC: A Network Meta-analysis

Authors

de Castro G; Stock GT; Harada G; Pereira AAL; Sadeghirad B

Volume

17

Pagination

pp. S426-S427

Publisher

ELSEVIER SCIENCE INC

Publication Date

September 1, 2022

Conference proceedings

JOURNAL OF THORACIC ONCOLOGY

Issue

9

ISSN

1556-0864

Contact the Experts team